Persist AI
Developing long-lasting drug formulations 50% faster
Woodland, United States · Founded 2022 · $4.0M raised
- Headquarters
- Woodland
- Employees
- 1–10
- Founded
- 2022
- Website
- persist-ai.com
- Total Funding
- $4.0M
- Last Round
- $4.0M SeedAug 2023
- Rounds
- 1
About
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
Summary
Persist AI is an Artificial Intelligence company based in Woodland, United States, founded in 2022. It has raised $4.0M in total across 1 round, most recently a $4.0M Seed round in Aug 2023. Investors include 2048 Ventures, Innospark Ventures and Fellows Fund.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2023
Investors
Similar Companies
Self-driving cars.
Saronic provides naval and maritime forces with intelligent Autonomous Surface Vessels at scale, ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Shield AI's mission is to protect service members and innocent civilians with artificially intell...